TERN- Terns Pharmaceuticals, Inc.

Name: Terns Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Terns Pharmaceuticals, Inc. (TERN) has 10 insiders with recent SEC Form 4 filings, including 6 buys and 23 sells. TERN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Burroughs Amy L.	296.5K	$15.70M	-
Other	Kuriakose Emil	112.5K	$5.96M	-
CFO	Gengos Andrew	101.8K	$5.39M	-
Dir	Lu Hongbo	45.0K	$2.38M	-
Dir	Fellows David A	2.8K	$149.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 16, 2024	Orbimed Advisors LLC67	Director, 10% Owner	Sell	56,164	$10.00	$561,640.00	-0.4%	-21.4%	-45.7%
Jul 16, 2024	Gordon Carl L74	Director, 10% Owner	Sell	56,164	$10.00	$561,640.00	-0.4%	-21.4%	-45.7%
Jul 16, 2024	Quigley Jill M.63	Director	Sale+OE	14,765	$10.00	$147,660.06	-19.7%	-21.4%	-45.7%
May 31, 2024	Vignola Mark J.67	Chief Financial Officer	Buy	4,791	$4.44	$21,272.04	+5.5%	+27.8%	-48.3%
May 31, 2024	Yoon Seokho Bryan62	COO And General Counsel	Buy	4,791	$4.44	$21,272.04	+5.5%	+27.8%	-48.3%
Apr 3, 2024	Vivo Opportunity, LLC67	10% Owner	Sell	420,663	$6.65	$2,796,859.03	-2.2%	+12.0%	-61.2%
Nov 30, 2023	Yoon Seokho Bryan62	COO And General Counsel	Buy	743	$3.78	$2,808.54	+4.2%	+68.3%	+40.2%
Nov 30, 2023	Vignola Mark J.67	Chief Financial Officer	Buy	743	$3.78	$2,808.54	+4.2%	+68.3%	+40.2%
May 31, 2023	Yoon Seokho Bryan62	COO And General Counsel	Buy	9,997	$1.41	$14,095.77	+130.5%	-48.2%	-33.8%
May 31, 2023	Sundaram Senthil Vel56	Chief Executive Officer	Buy	2,111	$1.41	$2,976.51	+27.6%	-48.2%	-33.8%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC